CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases

Autor: Valeria CENTO, Luna COLAGROSSI, Irene BOSSI, Daniele ARMENIA, Alice NAVA, Enrico PICCINELLI, Alessandro MALOBERTI, Elvira INGLESE, Elisa MATARAZZO, Federica DI RUSCIO, Pierpaolo PABA, Fabbio MARCUCCILLI, Marco PERRONE, Gaetano CHIRICOLO, Claudia ALTERI, Francesco SCAGLIONE, Chiara VISMARA, Daniela A. CAMPISI, Diana FANTI, Francesco ROMEO, Massimo ANDREONI, Fabrizio OLIVA, Francesca CECCHERINI-SILBERSTEIN, Cristina GIANNATTASIO, Carlo F. PERNO
Přispěvatelé: Cento, V, Colagrossi, L, Bossi, I, Armenia, D, Nava, A, Piccinelli, E, Maloberti, A, Inglese, E, Matarazzo, E, DI Ruscio, F, Paba, P, Marcuccilli, F, Perrone, M, Chiricolo, G, Alteri, C, Scaglione, F, Vismara, C, Campisi, D, Fanti, D, Romeo, F, Andreoni, M, Oliva, F, Ceccherini-Silberstein, F, Giannattasio, C, Perno, C
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Popis: Background: Acute coronary syndromes (ACS) are a major cause of morbidity and mortality. As cytomegalovirus (CMV) may contribute to Cardio-Vascular (CV) manifestations, we sought to provide a proof-of-concept for the involvement of coronary and/or systemic CMV-reactivation as a possible ACS trigger. Methods: We prospectively enrolled consecutive patients undergoing a coronary angiography for ACS (acute-cases, N=136), or non-ACS reasons (chronic-cases, N=57). Matched coronary and peripheral blood-samples were processed for quantification of CMV-DNAemia (RT-PCR), CMVIgG/ IgM, and CMV-IgG avidity (ELISA). Peripheral-blood samples from 17 healthy subjects were included as controls. Results: Out of the 193 cases included, 18.1% were aged ≤55 years, 92.5% were Central-European, and 100% immunocompetent. CMV-IgG seroprevalence was 91.7% (95%CI: 87.8-95.6), significantly higher than in healthy-controls (52.9% [95%CI: 29.2-76.5]; p
Databáze: OpenAIRE